Does EMICIZUMAB Cause Off label use? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Off label use have been filed in association with EMICIZUMAB (Hemlibra). This represents 13.8% of all adverse event reports for EMICIZUMAB.
101
Reports of Off label use with EMICIZUMAB
13.8%
of all EMICIZUMAB reports
7
Deaths
11
Hospitalizations
How Dangerous Is Off label use From EMICIZUMAB?
Of the 101 reports, 7 (6.9%) resulted in death, 11 (10.9%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMICIZUMAB. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does EMICIZUMAB Cause?
Haemarthrosis (77)
No adverse event (77)
Haemorrhage (72)
Haematoma (30)
Fall (23)
Headache (23)
Arthralgia (22)
Drug ineffective (21)
Head injury (21)
Muscle haemorrhage (19)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EMICIZUMAB Alternatives Have Lower Off label use Risk?
EMICIZUMAB vs EMICIZUMAB-KXWH
EMICIZUMAB vs EMPAGLIFLOZIN
EMICIZUMAB vs EMPAGLIFLOZIN\LINAGLIPTIN
EMICIZUMAB vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMICIZUMAB vs EMPAGLIFLOZIN\METFORMIN